Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager

Moberg Pharma AB (publ)

STO:MOB

Watchlist

Dividends

Price: 18.26 SEK -4.85% Market Closed

Market Cap: 852.6m SEK

Have any thoughts about
Moberg Pharma AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 18.26 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MOB Alert

Moberg Pharma AB (publ)

18.26

-0.93 (-4.85%)

52 Week Range	9.645 38.92
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Moberg Pharma AB (publ)

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Moberg Pharma AB (publ).

What unique competitive advantages
does Moberg Pharma AB (publ) hold over its rivals?

What risks and challenges
does Moberg Pharma AB (publ) face in the near future?

Has there been any significant insider trading activity
in Moberg Pharma AB (publ) recently?

Summarize the latest earnings call
of Moberg Pharma AB (publ).

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Moberg Pharma AB (publ).

Provide P/S
for Moberg Pharma AB (publ).

Provide P/E
for Moberg Pharma AB (publ).

Provide P/OCF
for Moberg Pharma AB (publ).

Provide P/FCFE
for Moberg Pharma AB (publ).

Provide P/B
for Moberg Pharma AB (publ).

Provide EV/S
for Moberg Pharma AB (publ).

Provide EV/GP
for Moberg Pharma AB (publ).

Provide EV/EBITDA
for Moberg Pharma AB (publ).

Provide EV/EBIT
for Moberg Pharma AB (publ).

Provide EV/OCF
for Moberg Pharma AB (publ).

Provide EV/FCFF
for Moberg Pharma AB (publ).

Provide EV/IC
for Moberg Pharma AB (publ).

Show me price targets
for Moberg Pharma AB (publ) made by professional analysts.

What are the Revenue projections
for Moberg Pharma AB (publ)?

How accurate were the past Revenue estimates
for Moberg Pharma AB (publ)?

What are the Net Income projections
for Moberg Pharma AB (publ)?

How accurate were the past Net Income estimates
for Moberg Pharma AB (publ)?

What are the EPS projections
for Moberg Pharma AB (publ)?

How accurate were the past EPS estimates
for Moberg Pharma AB (publ)?

What are the EBIT projections
for Moberg Pharma AB (publ)?

How accurate were the past EBIT estimates
for Moberg Pharma AB (publ)?

Compare the revenue forecasts
for Moberg Pharma AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Moberg Pharma AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Moberg Pharma AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of Moberg Pharma AB (publ) compared to its peers.

Compare the P/E ratios
of Moberg Pharma AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing Moberg Pharma AB (publ) with its peers.

Analyze the financial leverage
of Moberg Pharma AB (publ) compared to its main competitors.

Show all profitability ratios
for Moberg Pharma AB (publ).

Provide ROE
for Moberg Pharma AB (publ).

Provide ROA
for Moberg Pharma AB (publ).

Provide ROIC
for Moberg Pharma AB (publ).

Provide ROCE
for Moberg Pharma AB (publ).

Provide Gross Margin
for Moberg Pharma AB (publ).

Provide Operating Margin
for Moberg Pharma AB (publ).

Provide Net Margin
for Moberg Pharma AB (publ).

Provide FCF Margin
for Moberg Pharma AB (publ).

Show all solvency ratios
for Moberg Pharma AB (publ).

Provide D/E Ratio
for Moberg Pharma AB (publ).

Provide D/A Ratio
for Moberg Pharma AB (publ).

Provide Interest Coverage Ratio
for Moberg Pharma AB (publ).

Provide Altman Z-Score Ratio
for Moberg Pharma AB (publ).

Provide Quick Ratio
for Moberg Pharma AB (publ).

Provide Current Ratio
for Moberg Pharma AB (publ).

Provide Cash Ratio
for Moberg Pharma AB (publ).

What is the historical Revenue growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the historical Net Income growth
over the last 5 years for Moberg Pharma AB (publ)?

What is the current Free Cash Flow
of Moberg Pharma AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for Moberg Pharma AB (publ).

EV/GP
Enterprise Value to Gross Profit

159.9

Current

Median

5.2

Industry

Higher than median

Higher than industry value

All Countries

Forward Multiples

			Market Cap	EV/GP
SE		Moberg Pharma AB (publ) STO:MOB	836.9m SEK	159.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	776 550.9T JPY	-164 697 976
US		Eli Lilly and Co NYSE:LLY	710.5B USD	22.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	440.4B GBP	1 026
DK		Novo Nordisk A/S CSE:NOVO B	3.3T DKK	14.4
US		Johnson & Johnson NYSE:JNJ	373.5B USD	6.4
US		Merck & Co Inc NYSE:MRK	251.1B USD	5.6
CH		Roche Holding AG SIX:ROG	202.7B CHF	5.1
CH		Novartis AG SIX:NOVN	183.3B CHF	5.7
UK		AstraZeneca PLC LSE:AZN	162.4B GBP	64.8
IE	E	Endo International PLC LSE:0Y5F	146B USD	97.4


SE		Moberg Pharma AB (publ) STO:MOB	Average EV/GP: 140.7 159.9
JP	N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Negative Multiple: -164 697 976
US		Eli Lilly and Co NYSE:LLY	22.3
UK		Dechra Pharmaceuticals PLC LSE:DPH	1 026
DK		Novo Nordisk A/S CSE:NOVO B	14.4
US		Johnson & Johnson NYSE:JNJ	6.4
US		Merck & Co Inc NYSE:MRK	5.6
CH		Roche Holding AG SIX:ROG	5.1
CH		Novartis AG SIX:NOVN	5.7
UK		AstraZeneca PLC LSE:AZN	64.8
IE	E	Endo International PLC LSE:0Y5F	97.4

EV/GP Forward Multiples

Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/GP

N/A

2-Years Forward

EV/GP

N/A

3-Years Forward

EV/GP

N/A

Moberg Pharma AB (publ)
STO:MOB

EV/GP
Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Moberg Pharma AB (publ) STO:MOB

EV/GP Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Moberg Pharma AB (publ)
STO:MOB

EV/GP
Enterprise Value to Gross Profit